-
Article
Open AccessConcentration of novel urinary tract infection biomarkers in neonates
Urinary tract infections (UTIs) are a common comorbidity in hospitalized neonates. The current UTI diagnostics have several limitations including invasive collection of urinary samples to ensure sterility, ris...
-
Article
Kidney support for babies: building a comprehensive and integrated neonatal kidney support therapy program
Kidney support therapy (KST), previously referred to as Renal Replacement Therapy, is utilized to treat children and adults with severe acute kidney injury (AKI), fluid overload, inborn errors of metabolism, a...
-
Article
Positive fluid balance and diuretic therapy are associated with mechanical ventilation and mortality in preterm neonates in the first fourteen postnatal days
Fluid overload leads to poor neonatal outcomes. Diuretics may lower the rates of mechanical ventilation (MV) and mortality in neonates with fluid overload.
-
Article
Nephrotoxic medications and associated acute kidney injury in hospitalized neonates
Hospitalized neonates are often treated with nephrotoxic medications, a known risk factor for acute kidney injury (AKI). Nephrotoxic medications and AKI, especially in periviable neonates, could be detrimental...
-
Article
Improving the identification of acute kidney injury in the neonatal ICU: three centers’ experiences
To describe three different standardized approaches to improving neonatal acute kidney injury (AKI) identification and the impact on AKI identification, incidence, and nephrology consultation and referral.
-
Article
Diuretic therapy and acute kidney injury in preterm neonates and infants
Acute kidney injury (AKI) in preterm infants is associated with prolonged hospitalization and high mortality. Diuretic therapy has been used to enhance urine output in preterm infants with AKI. Treatment with ...
-
Article
Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels
To identify the relationship between prophylactic indomethacin (PI) administration and (1) mortality and bronchopulmonary dysplasia (BPD) at 36-week postmenstrual age (PMA) (primary outcome), and (2) to evalua...
